Showing results (81-90 of 87) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Journal of Medicinal Chemistry|October 1, 2004
Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disordersHenry J Breslin, Tamara A Miskowski, Bryan M Rafferty, et al.The Journal of Pharmacology and Experimental Therapeutics|January 20, 2009
JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependenceEllen E Codd, John R Carson, Raymond W Colburn, et al.Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonistsBin Zhu, Mingde Xia, Xiaoqing Xu, et al.The Journal of Pharmacology and Experimental Therapeutics|June 13, 2006
The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent mu opioid RWJ-413216E E Codd, J R Carson, R W Colburn, et al.Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|July 10, 2010
Diabetogenic effect of a series of tricyclic delta opioid agonists structurally related to cyproheptadineEllen E Codd, Judith Baker, Michael R Brandt, et al.Experimental Neurology|April 23, 2015
Large animal and primate models of spinal cord injury for the testing of novel therapiesBrian K Kwon, Femke Streijger, Caitlin E Hill, et al.Pageof 9